Recent Updates
Recently added Catalysts
BSX

Boston Scientific to Participate in Leerink Swann 2012 Global Healthcare Conference Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Leerink Swann 2012 Global Healthcare Conference on February 15 in New...

Key Takeaway: NATICK, Mass. , Feb. 7, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX ) is scheduled to participate in the Leerink Swann 2012 Global Healthcare Conference on February 15 in New York . Hank Kucheman , Chief Executive Officer, Mike Mahoney , President, and Jeff Cap

Full Press Release Details

NATICK, Mass. , Feb. 7, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX ) is scheduled to participate in the Leerink Swann 2012 Global Healthcare Conference on February 15 in New York .
Hank Kucheman , Chief Executive Officer, Mike Mahoney , President, and Jeff Capello , Executive Vice President and Chief Financial Officer, will participate in a 30-minute question and answer session regarding the Company beginning at approximately 11:00 a.m. ET .
A live webcast of the question and answer session will be available to all interested parties via Boston Scientific's website. Webcast registration is available on the Investor Relations section of the website at www.bostonscientific.com/investors . Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.
This webcast is being hosted by Leerink Swann. The replay will be archived and available at www.bostonscientific.com/investors beginning approximately one hour following the completion of the question and answer session.
About Boston Scientific
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com .
CONTACT: Denise Kaigler
508-650-8330 (office)
Media Relations
Boston Scientific Corporation
[email protected]
Eric Olson
336-293-4393 (office)
Media Relations
Boston Scientific Corporation
[email protected]
Sean Findlen
617-520-7268 (office)
Media Relations
Weber Shandwick
[email protected]
Sean Wirtjes
508-652-5305 (office)
Investor Relations
Boston Scientific Corporation
[email protected]
SOURCE Boston Scientific Corporation

21 %

Last updated: Feb 7, 2012